1.Metastasis of Transitional Cell Carcinoma to the Lower Abdominal Wall 20 Years after Cystectomy.
Ja Hyeon KU ; Woon Geol YEO ; Min Young PARK ; Eun Sik LEE ; Hyeon Hoe KIM
Yonsei Medical Journal 2005;46(1):181-183
Iatrogenic implantation has been the main cause in the majority of cases of transitional call carcinoma (TCC) with metastasis to the abdominal wall. A 66-year-old woman had undergone radical cystectomy 20 years prior to presenting. Radiological investigations revealed one mass in the left lower abdominal wall and one mass in the right inguinal area. She underwent wide excision of the lesions that revealed metastasis of TCC. This report describes this case of a woman with bladder carcinoma who developed a metastasis in the anterior abdominal wall following an apparent disease-free interval of 20 years.
Abdominal Wall/*pathology
;
Aged
;
Bladder Neoplasms/*pathology/*surgery
;
Carcinoma, Transitional Cell/*secondary/*surgery
;
Cystectomy
;
Female
;
Humans
;
Soft Tissue Neoplasms/*secondary
;
Time Factors
2.Metastatic bladder cancer presenting as duodenal obstruction.
Katherine HAWTIN ; Alex KENT ; Carole COLLINS ; Dominic BLUNT
Annals of the Academy of Medicine, Singapore 2009;38(10):914-912
INTRODUCTIONBladder cancer is a common malignancy but presentation with metastatic disease is rare. This is the fi rst reported case of duodenal obstruction as a presentation of metastatic bladder cancer.
CLINICAL PICTUREA middle-aged woman presented with nausea, vomiting, weight loss and intermittent haematuria. Radiology and histology confirmed metastatic bladder cancer to the retroperitoneum encasing the duodenum and causing obstruction.
TREATMENTInsertion of a duodenal stent relieved the obstruction and palliative chemoradiotherapy was initiated.
OUTCOMEThe patient died 15 months after diagnosis.
CONCLUSIONSClinicians and radiologists should be aware of atypical presentations of common malignancies.
Adult ; Carcinoma, Transitional Cell ; drug therapy ; secondary ; Diagnosis, Differential ; Duodenal Obstruction ; diagnosis ; etiology ; surgery ; Fatal Outcome ; Female ; Humans ; Palliative Care ; Retroperitoneal Neoplasms ; complications ; diagnosis ; secondary ; Stents ; Urinary Bladder Neoplasms ; drug therapy ; pathology
3.Sarcomatoid carcinoma in urinary bladder: report of a case.
Ai-jing SUN ; Li-ping SUN ; Di-lai HUANG
Chinese Journal of Pathology 2009;38(3):203-204
Aged
;
Antibodies, Monoclonal
;
metabolism
;
Carcinoma, Transitional Cell
;
metabolism
;
pathology
;
surgery
;
Cystectomy
;
Follow-Up Studies
;
Humans
;
Keratin-7
;
metabolism
;
Keratins
;
immunology
;
Lung Neoplasms
;
secondary
;
Male
;
Urinary Bladder Neoplasms
;
metabolism
;
pathology
;
surgery
;
Vimentin
;
metabolism
4.Predictors of Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: An Inflammation-Based Prognostic Score.
Yang Hyun CHO ; Young Ho SEO ; Seung Jun CHUNG ; Insang HWANG ; Ho Song YU ; Sun Ouck KIM ; Seung Il JUNG ; Taek Won KANG ; Dong Deuk KWON ; Kwangsung PARK ; Jun Eul HWANG ; Suk Hee HEO ; Geun Soo KIM ; Eu Chang HWANG
Korean Journal of Urology 2014;55(7):453-459
PURPOSE: Systemic inflammatory responses, which are defined in terms of the Glasgow prognostic score (GPS), have been reported to be independent predictors of unfavorable outcomes in various human cancers. We assessed the utility of the GPS as a predictor of intravesical recurrence after radical nephroureterectomy (RNU) in upper urinary tract carcinoma (UTUC). MATERIALS AND METHODS: We collected data for 147 UTUC patients with no previous history of bladder cancer who underwent RNU from 2004 to 2012. Associations between perioperative clinicopathological variables and intravesical recurrence were analyzed by using univariate and multivariate Cox regression models. RESULTS: Overall, 71 of 147 patients (48%) developed intravesical recurrence, including 21 patients (30%) diagnosed with synchronous bladder tumor. In the univariate analysis, performance status, diabetes mellitus (DM), serum albumin, C-reactive protein, GPS, and synchronous bladder tumor were associated with intravesical recurrence. In the multivariate analysis, performance status (hazard ratio [HR], 2.33; 95% confidence interval [CI], 1.41-3.85; p=0.001), DM (HR, 2.04; 95% CI, 1.21-3.41; p=0.007), cortical thinning (HR, 2.01; 95% CI, 1.08-3.71; p=0.026), and GPS (score of 1: HR, 6.86; 95% CI, 3.69-12.7; p=0.001; score of 2: HR, 5.96; 95% CI, 3.10-11.4; p=0.001) were independent predictors of intravesical recurrence. CONCLUSIONS: Our results suggest that the GPS as well as performance status, DM, and cortical thinning are associated with intravesical recurrence after RNU. Thus, more careful follow-up, coupled with postoperative intravesical therapy to avoid bladder recurrence, should be considered in these patients.
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Transitional Cell/pathology/secondary/*surgery
;
Female
;
Humans
;
Male
;
Middle Aged
;
Neoplasm Grading
;
Neoplasm Recurrence, Local/*etiology
;
Neoplasm Staging
;
Nephrectomy/*methods
;
Prognosis
;
Retrospective Studies
;
Risk Factors
;
Survival Analysis
;
Systemic Inflammatory Response Syndrome/etiology
;
Ureter/surgery
;
Urinary Bladder Neoplasms/secondary
;
Urologic Neoplasms/pathology/*surgery